Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Elixinol Wellness ( (AU:EXL) ) has provided an announcement.
Elixinol Wellness reported record-breaking growth in Q4 FY24 with a 71% increase in cash receipts and a 64% rise in quarterly revenue. The company’s strategic integration of acquisitions, such as Healthy Chef, has accelerated growth and expanded market opportunities, particularly in Australia and the U.S., while maintaining robust margin improvements and nearing EBITDA break-even, ensuring financial stability for future expansion.
More about Elixinol Wellness
Elixinol Wellness operates in the wellness industry, focusing on hemp-derived products and health supplements, with a market emphasis on Australia and the U.S.
YTD Price Performance: 27.78%
Average Trading Volume: 1,637
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.37M
See more data about EXL stock on TipRanks’ Stock Analysis page.
